StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines cEO Pay Ratio (x:1, DEF 14A Proxy Statement) (×)

DEF 14A Proxy Statement (CEO Pay Ratio & ECD Pay vs. Performance)

Latest, FY2025
218.00
Period ended Dec 31, 2025
Change on a year earlier
-7.2%
235.00 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCEO Pay Ratio (x:1, DEF 14A Proxy Statement) (×)Year on yearSource
FY2025Dec 31, 2025218.00-7.2%Proxy Statement (DEF 14A) (filed 2026-04-28) ↗
FY2024Dec 31, 2024235.00-3.7%Proxy Statement (DEF 14A) (filed 2025-04-07) ↗
FY2023Dec 31, 2023244.00+5.6%Proxy Statement (DEF 14A) (filed 2024-04-26) ↗
FY2022Dec 31, 2022231.00+1.3%Proxy Statement (DEF 14A) (filed 2023-04-27) ↗
FY2021Dec 31, 2021228.00+21.9%Proxy Statement (DEF 14A) (filed 2022-04-29) ↗
FY2020Dec 31, 2020187.00–Proxy Statement (DEF 14A) (filed 2021-04-30) ↗

Breakdown

What makes up ceo pay ratio (x:1, def 14a proxy statement)

Cite this data

StockData. (2026). BeOne Medicines CEO Pay Ratio (x:1, DEF 14A Proxy Statement) (×), annual FY2020–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/ceo_pay_ratio

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.